Table 1.
Baseline demographic and medical characteristics of all included patients (n=955)
| Control group (n=469) | Intervention group (n=486) | |
|---|---|---|
| Age, years | ||
| Mean (95% CI) | 63.6 (62.5 to 64.6) | 63.2 (62.2 to 64.3) |
| Median | 64 | 64 |
| Range | 21 to 98 | 28 to 92 |
| Sex, n (%) | ||
| Male | 134 (28.6) | 133 (27.4) |
| Female | 335 (71.4) | 353 (72.6) |
| Cancer type, n (%) | ||
| Cancer of the breast | 206 (43.9) | 201 (41.4) |
| Cancer of the lung | 69 (14.7) | 75 (15.4) |
| Malignant melanoma | 44 (9.4) | 35 (7.2) |
| Cancer of the rectum/anus | 33 (7.0) | 45 (9.3) |
| Cancer of the colon | 29 (6.2) | 39 (8.0) |
| Cancer of the ovaries | 12 (2.6) | 9 (1.9) |
| Cancer of the bilary system | 7 (1.5) | 8 (1.6) |
| Cancer of the brain | 6 (1.3) | 8 (1.6) |
| Cancer of the prostate | 8 (1.7) | 3 (0.6) |
| Cancer of the corpus uteri | 6 (1.3) | 5 (1.0) |
| Myelomatosis | 6 (1.3) | 5 (1.0) |
| Lymphoma | 3 (0.6) | 4 (0.8) |
| Unspecified location | 16 (3.4) | 16 (3.3) |
| Other diagnoses | 24 (5.1) | 33 (6.8) |